8 studies were found.

1.		No longer recruiting	Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Condition: Lymphoma
2.		No longer recruiting	Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma Condition: Lymphoma
3.		Completed	Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Conditions: Colorectal Cancer; Colon Cancer; Rectal Cancer; Colorectal Neoplasms; Colorectal Carcinoma; Colorectal Tumor
4.		Terminated	Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients with Limited Residual Disease After Surgery Condition: Colorectal Neoplasms
5.		Completed	Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer Condition: Pancreatic Neoplasms
6.		No longer recruiting	Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer Conditions: Colorectal Cancer; Colon Cancer; Rectal Cancer; Colorectal Neoplasms; Colorectal Carcinoma; Breast Cancer; Breast Neoplasms
7.		Not yet recruiting	Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma Condition: Non-Hodgkins Lymphoma
8.		No longer recruiting	Treatment of Non-Hodgkin's Lymphoma with 90Y-hLL2 IgG Conditions: Non-Hodgkin's Lymphoma; Lymphoma, B-Cell